STOCK TITAN

RadNet (RDNT) legal chief reports exercise of 3,396 stock options

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

RadNet, Inc. reported an insider stock transaction by an executive who serves as Executive Vice President and Chief Legal Officer. On 12/10/2025, this reporting person exercised employee stock options to acquire 3,396 shares of RadNet common stock at an exercise price of $29.44 per share, bringing their directly held common stock to 71,577 shares.

The exercised options are part of a grant originally issued on January 4, 2022 for up to 29,140 shares, subject to time-based vesting. One-third vested on January 4, 2022, with the remaining two-thirds vesting in three equal installments on January 3, 2023, January 3, 2024, and January 3, 2025. After this transaction, the reporting person continues to beneficially own 15,556 employee stock options, which are scheduled to expire on January 3, 2032.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Katz David Jeffrey

(Last) (First) (Middle)
C/O RADNET, INC.
1510 COTNER AVE.

(Street)
LOS ANGELES CA 90025

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
RadNet, Inc. [ RDNT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP and Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/10/2025 M 3,396(1) A $29.44 71,577 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) $29.44 12/10/2025 M 3,396 (2) 01/03/2032 Common Stock 3,396 $0 15,556 D
Explanation of Responses:
1. Exercise of previously granted option.
2. On January 4, 2022, the reporting person was granted a stock option to purchase up to 29,140 shares of common stock of RadNet, Inc., subject to time-based vesting. Subject to the reporting person's continued service, the stock option vested as to one-third on January 4, 2022 and vested with respect to the remaining two-thirds of the shares in three equal installments on January 3, 2023, January 3, 2024, and January 3, 2025.
/s/ Jose Gamez, Attorney-in-Fact 12/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did RadNet (RDNT) disclose in this Form 4?

The filing shows that an executive at RadNet, Inc. exercised employee stock options on 12/10/2025 to acquire 3,396 shares of common stock at an exercise price of $29.44 per share.

What is the reporting persons role at RadNet (RDNT)?

The reporting person is identified as an officer of RadNet, serving as Executive Vice President and Chief Legal Officer.

How many RadNet (RDNT) shares does the insider own after the transaction?

Following the reported option exercise, the insider beneficially owns 71,577 shares of RadNet common stock in direct ownership.

What were the original terms of the RadNet (RDNT) stock option grant?

On January 4, 2022, the reporting person received a stock option to purchase up to 29,140 shares of RadNet common stock, subject to time-based vesting: one-third vested on January 4, 2022, and the remaining two-thirds vested in three equal installments on January 3, 2023, January 3, 2024, and January 3, 2025, contingent on continued service.

How many RadNet (RDNT) stock options does the insider still hold after this exercise?

After exercising part of the grant, the reporting person continues to beneficially own 15,556 employee stock options related to RadNet common stock, with an expiration date of January 3, 2032.

What type of derivative security was involved in the RadNet (RDNT) Form 4 transaction?

The transaction involved an Employee Stock Option (right to buy) RadNet common stock, with a stated exercise price of $29.44 per share and an expiration date of January 3, 2032.

Radnet

NASDAQ:RDNT

RDNT Rankings

RDNT Latest News

RDNT Latest SEC Filings

RDNT Stock Data

5.93B
67.21M
12.73%
94.2%
7.83%
Diagnostics & Research
Services-medical Laboratories
Link
United States
LOS ANGELES